Spots Global Cancer Trial Database for liver transplantation
Every month we try and update this database with for liver transplantation cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Evaluation of Stereotactic Body Radiotherapy as a Bridge Therapy for Hepatocellular Carcinoma Patients Enlisted for Liver Transplantation | NCT06218420 | Hepatocellular ... | Stereotactic Bo... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Resection And Partial LIver Transplantation With Delayed Hepatectomy for Hepatocellular Carcinoma | NCT05971628 | Hepatocellular ... | RAPID procedure | 18 Years - 68 Years | Assistance Publique - Hôpitaux de Paris | |
| Partial Liver Segment 2/3 Transplantation Study | NCT02215889 | Colorectal Canc... | Liver transplan... | 18 Years - | Oslo University Hospital | |
| Lenvatinib Therapy in HCC Patients After LDLT | NCT05572528 | Liver Transplan... Hepatocellular ... | 18 Years - 75 Years | Kaoshiung Chang Gung Memorial Hospital | ||
| Liver Transplantation for Unresectable GIST Liver Metastases | NCT04825470 | Liver Diseases Liver Cancer Liver Metastase... Liver Neoplasms Liver Mass Liver Carcinoma Liver Transplan... Liver Transplan... GIST GIST, Malignant Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Metastases to L... Metastatic Live... Metastasis Metastases Liver Transplan... Transplant Onco... | Liver Transplan... | 18 Years - | Hospital Universitario Virgen de la Arrixaca | |
| Safety Study of NK Cells From Sibship to Treat the Recurrence of HCC After Liver Transplantation | NCT02399735 | Hepatocellular ... | Low Dose NK cel... Normal Dose NK ... Normal Dose NK ... | 18 Years - 65 Years | Third Affiliated Hospital, Sun Yat-Sen University | |
| Safety and Efficacy of Camrelizumab (Anti-PD-1 Antibody) in Recurrent HCC After Liver Transplantation | NCT04564313 | Hepatocellular ... Liver Transplan... | Camrelizumab tr... | 18 Years - 65 Years | Third Affiliated Hospital, Sun Yat-Sen University | |
| Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients | NCT05171335 | Hepatocellular ... | Lenvatinib Transcatheter A... | 18 Years - | The Methodist Hospital Research Institute | |
| Liver Transplantation and Metastatic Colo-rectal Cancer. | NCT00294827 | Colo-rectal Can... | Liver transplan... | 18 Years - | Oslo University Hospital | |
| Correlation Between Pre-transplant ICI Exposure and Post-transplant Graft Rejection | NCT05913583 | Graft Rejection Hepatocellular ... Immunotherapy Immune Checkpoi... | Immune checkpoi... | 18 Years - 75 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer | NCT00980460 | PRETEXT I Hepat... PRETEXT II Hepa... PRETEXT III Hep... PRETEXT IV Hepa... | Cisplatin Dexrazoxane Doxorubicin Hyd... Fluorouracil Irinotecan Hydr... Laboratory Biom... Liver Transplan... Temsirolimus Therapeutic Con... Vincristine Sul... | - 21 Years | National Cancer Institute (NCI) | |
| The ImmunoXXL Study | NCT05879328 | Hepatocellular ... | Liver Transplan... | 18 Years - 75 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Adult-to-Adult Living Donor Transplant Cohort Study | NCT01619475 | Liver Diseases Hepatocellular ... End Stage Liver... Hepatitis C Liver Cirrhosis | 18 Years - | Arbor Research Collaborative for Health | ||
| Liver Transplantation for Unresectable GIST Liver Metastases | NCT04825470 | Liver Diseases Liver Cancer Liver Metastase... Liver Neoplasms Liver Mass Liver Carcinoma Liver Transplan... Liver Transplan... GIST GIST, Malignant Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Metastases to L... Metastatic Live... Metastasis Metastases Liver Transplan... Transplant Onco... | Liver Transplan... | 18 Years - | Hospital Universitario Virgen de la Arrixaca | |
| Liver Transplantation in Patients With Incidental Hepatocellular-cholangiocarcinoma and Intrahepatic Cholangiocarcinoma: A Single-center Experience | NCT04848805 | Adult Combined ... | liver transplan... | 18 Years - 78 Years | Istanbul Demiroglu Bilim University | |
| Long-term Outcomes of Ablation, Liver Resection, and Liver Transplant as First-line Treatment for Solitary HCC of 3 cm or Less | NCT05193253 | Hepatocellular ... | Radiofrequency ... Liver resection Liver transplan... | 18 Years - | University Health Network, Toronto | |
| Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation | NCT00080236 | Liver Transplan... Hepatitis Cholestasis Carcinoma, Hepa... | IDN-6556 Placebo | 18 Years - | Conatus Pharmaceuticals Inc. | |
| PET TDM FDG-Choline as a Decision-making Tool for Routine Care on the Liver Transplant List for HCC | NCT04792801 | Hepatocellular ... Liver Transplan... | PET TDM FDG-Cho... | 18 Years - | University Hospital, Lille | |
| Liver Transplantation With ADV-TK Gene Therapy Improves Survival in Patients With Advanced Hepatocellular Carcinoma | NCT00300521 | Hepatocellular ... Liver Transplan... | ADV-TK (adenovi... | 0 Years - | Beijing Chao Yang Hospital | |
| The Effect of Vitamin D Repletion in Patients With Hepatocellular Carcinoma on the Orthotopic Liver Transplant List | NCT01575717 | Vitamin D Defic... Hepatocellular ... | Vitamin D3 4000... Vitamin D3 2000... | 18 Years - | Icahn School of Medicine at Mount Sinai | |
| Use of N-Acetylcysteine During Liver Procurement | NCT01394497 | Liver Failure Liver Failure, ... Liver Diseases Carcinoma, Hepa... Liver Neoplasms | N-acetylcystein | 18 Years - | Azienda Ospedaliera di Padova | |
| Persistent Lymphopenia in Liver Transplantation and Its Molecular Insights for Hepatocellular Carcinoma | NCT06368349 | Lymphopenia | 20 Years - 80 Years | Chang Gung Memorial Hospital | ||
| Safety Study of NK Cells From Sibship to Treat the Recurrence of HCC After Liver Transplantation | NCT02399735 | Hepatocellular ... | Low Dose NK cel... Normal Dose NK ... Normal Dose NK ... | 18 Years - 65 Years | Third Affiliated Hospital, Sun Yat-Sen University | |
| Preliminary Results for the Double-dose Adenovirus-mediated Adjuvant Therapy Improving Outcome of Liver Transplantation in Patients With Advanced Hepatocellular Carcinoma | NCT02202564 | Liver Cancer Hepatocellular ... | LT ADV-TK ganciclovir | 18 Years - 70 Years | Huazhong University of Science and Technology | |
| Liver Transplantation With Two-stage Liver Resection in Unresectable Liver Cancer , Metastases or Emd-stage Liver Disease (LTLR-LC) | NCT05750329 | Liver Transplan... Hepatic Cancer End-stage Liver... | assisted liver ... | 18 Years - 75 Years | RenJi Hospital | |
| Liver Transplantation After ex Vivo Liver Perfusion | NCT05951231 | Liver Transplan... Transplant; Fai... Transplant Dysf... Transplant; Com... Transplant Liver Metastase... Liver Cancer | Liver transplan... | 18 Years - 100 Years | Oslo University Hospital | |
| COVID-19 in Immunosuppressed Children | NCT04511429 | Infections, Cor... Kidney Transpla... Liver Transplan... Cancer Covid19 | 1 Month - 18 Years | D'Or Institute for Research and Education | ||
| Comparison of Criteria for Liver Transplantation in Hepatocellular Carcinoma | NCT04576572 | Hepatocellular ... Liver Cancer Advanced Adult ... Cirrhosis, Live... Unresectable Li... Liver Transplan... | - | Inonu University | ||
| HAI-Floxuridine, or Liver-Tx, Combined With 2nd Line Chemotherapy Versus 2nd Line Chemotherapy Alone for Patients With Colorectal Liver Metastases and Heavy Tumour Burden. | NCT04898504 | Colorectal Canc... Liver Metastase... Chemotherapy Ef... | Floxuridine Liver Transplan... | 18 Years - | Oslo University Hospital | |
| Orthotopic Liver Transplantation Using a Living Donor | NCT00152607 | Liver Disease Liver Neoplasms | donor right hep... | 18 Years - 55 Years | University of Chicago | |
| Serum Glycomics as Prognostic and Diagnostic Biomarkers of Disease Recurrence in Liver Transplant Recipients With Hepatocellular Carcinoma | NCT05866783 | Prognostic Biom... Liver Transplan... Diagnostic Biom... Hepatocellular ... | HCCRecurrencePr... HCCRecurrenceDi... | 18 Years - | University Hospital, Ghent | |
| Study of PD/PK/PG Relationships of Tacrolimus and Cyclosporin in Liver Transplant Patients | NCT01760356 | End Stage Liver... Rejection Infection Malignancy Toxicity Diabetes | 18 Years - 70 Years | UDA Centro Nacional Hepato-Bilio-Pancreático | ||
| Microbiota Study in Liver Transplanted Patients | NCT03507140 | Cirrhosis Hepatocellular ... Liver Transplan... Microbiota | Multiple sampli... | 18 Years - 70 Years | University Hospital, Grenoble | |
| COVID-19 in Immunosuppressed Children | NCT04511429 | Infections, Cor... Kidney Transpla... Liver Transplan... Cancer Covid19 | 1 Month - 18 Years | D'Or Institute for Research and Education | ||
| Liver Transplantation for Non-resectable Colorectal Liver Metastases: Translational Research | NCT05398380 | Colorectal Canc... Liver Metastase... Genetic Change | Liver transplan... | 18 Years - 70 Years | Hospital Vall d'Hebron | |
| Relenvatinib in the Tatment of Recurrence of Hepatocellular Carcinoma After Liver Transplantation | NCT04237740 | Hepatocellular ... Liver Transplan... | relenvatinib | 18 Years - 75 Years | RenJi Hospital | |
| Lenvatinib Following Liver Transplantation in Patients of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus | NCT04319484 | Hepatocellular ... Portal Vein Tum... Liver Transplan... | lenvatinib Placebo | 1 Year - 75 Years | RenJi Hospital | |
| Liver Transplantation for Hilar Cholangiocarcinoma in Association With Neoadjuvant Radio- and Chemo-therapy | NCT01549795 | Hilar Cholangio... Primary Scleros... | Liver transplan... 45 Gy external ... Endoluminal bil... Capecitabine Pre liver trans... | 18 Years - 65 Years | Azienda Ospedaliera di Padova | |
| Safety and Efficacy of Camrelizumab (Anti-PD-1 Antibody) in Recurrent HCC After Liver Transplantation | NCT04564313 | Hepatocellular ... Liver Transplan... | Camrelizumab tr... | 18 Years - 65 Years | Third Affiliated Hospital, Sun Yat-Sen University | |
| Living Donor Liver Transplant for Unresectable Colorectal Liver Metastases | NCT05248581 | Colorectal Canc... | Liver transplan... | 18 Years - | University of Rochester | |
| Liver Transplantation for Non-resectable Colorectal Liver Metastases: Translational Research | NCT05398380 | Colorectal Canc... Liver Metastase... Genetic Change | Liver transplan... | 18 Years - 70 Years | Hospital Vall d'Hebron | |
| Liver Transplantation Compared to Chemotherapy in Patients With ColoRectal Cancer | NCT03494946 | Liver Metastase... Colorectal Canc... | Liver transplan... Chemotherapy | 18 Years - | Oslo University Hospital | |
| Partial Liver Segment 2/3 Transplantation Study | NCT02215889 | Colorectal Canc... | Liver transplan... | 18 Years - | Oslo University Hospital | |
| Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation | NCT01151761 | Cholangiocarcin... Hepatobiliary N... Liver Cancer Bile Duct Cance... Cancer of Gallb... | Stereotactic Bo... Gemcitabine Cisplatin Carboplatin Capecitabine 5FU Liver transplan... | 18 Years - | Stanford University | |
| Expansion of Conventional Criteria for Liver Transplantation in Hepatocellular Carcinoma Through Downstaging | NCT01387503 | Carcinoma, Hepa... Cirrhosis | Liver transplan... | 18 Years - 65 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| A Worldwide Score for Hepatocellular Cancer and Liver Transplantation | NCT03595345 | Liver Cancer Dropout, Patien... Recurrence | Liver transplan... | 18 Years - | European Hepatocellular Cancer Liver Transplant Group | |
| Lenvatinib Following Liver Transplantation in Patients With High-Risk Hepatocellular Carcinoma | NCT04168944 | Hepatocellular ... | Lenvatinib Placebo Immunosuppressi... | 18 Years - 75 Years | RenJi Hospital | |
| Lenvatinib Treatment in Waiting List of Liver Transplantation After TACE Failure in Patients With Hepatocellular Carcinoma | NCT05901194 | Hepatocellular ... | Lenvatinib | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients | NCT05171335 | Hepatocellular ... | Lenvatinib Transcatheter A... | 18 Years - | The Methodist Hospital Research Institute | |
| Liver Transplantation and Uveal Malignant Melanoma | NCT01311466 | Uveal Malignant... | Liver transplan... | 18 Years - 65 Years | Oslo University Hospital | |
| Living Donor Liver Transplantation With Two Stage Hepatectomy for Patients With Isolated, Irresectable Colorectal Liver Metastases | NCT03488953 | Colorectal Canc... Liver Metastase... | Living donor li... | 18 Years - | Jena University Hospital | |
| Impact of "No-touch" Technique on the Outcome of Liver Transplantation for Hepatocellular Carcinoma | NCT06331273 | Liver Transplan... No-touch Techni... Hepatocellular ... | Liver transplan... | 18 Years - | Zhejiang University | |
| LIver TrAnspLantation for Non-resectable Peri-HIlar cholangioCArcinoma (LITALHICA) | NCT06125769 | Perihilar Chola... | Liver transplan... | 18 Years - 70 Years | Azienda Sanitaria Ospedaliera | |
| SBRT for Liver Cancer Before Liver Transplantation | NCT04186234 | Liver Cancer Liver Transplan... | Stereotactic bo... | 18 Years - | The University of Hong Kong | |
| Liver Transplantation for Hilar Cholangiocarcinoma in Association With Neoadjuvant Radio- and Chemo-therapy | NCT01549795 | Hilar Cholangio... Primary Scleros... | Liver transplan... 45 Gy external ... Endoluminal bil... Capecitabine Pre liver trans... | 18 Years - 65 Years | Azienda Ospedaliera di Padova | |
| Liver Transplant for Stable, Advanced Intrahepatic Cholangiocarcinoma | NCT04195503 | Cholangiocarcin... | Liver Transplan... | 18 Years - | University Health Network, Toronto | |
| Neo-adjuvant Peptide Receptor Mediated Radiotherapy With 177Lutetium in Front of Curative Intended Liver Transplantation in Patients With Hepatic Metastasis of Neuroendocrine Tumors (NEO-LEBE) | NCT01201096 | Liver Metastasis Neuroendocrine ... | 177Lutetium Liver transplan... | 18 Years - 60 Years | University of Jena | |
| Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation | NCT01151761 | Cholangiocarcin... Hepatobiliary N... Liver Cancer Bile Duct Cance... Cancer of Gallb... | Stereotactic Bo... Gemcitabine Cisplatin Carboplatin Capecitabine 5FU Liver transplan... | 18 Years - | Stanford University | |
| Outcome Analysis of Aspirin in Liver Transplantation | NCT04327427 | Liver Transplan... | Aspirin | 18 Years - | University of Zurich | |
| HOPE to Reduce Tumour Recurrence After LT In Patients With HCC | NCT05876052 | Liver Cancer Tumor Recurrenc... Hepatocellular ... Liver Transplan... Ex-vivo Hypothe... | Hypothermic oxy... | 18 Years - | University of Bologna | |
| Transarterial Chemoembolization Prior to Transplantation for Hepatocellular Carcinoma | NCT01676194 | Hepatocellular ... | Intra-arterial ... | 18 Years - | Rennes University Hospital | |
| Adult-to-Adult Living Donor Liver Transplantation Study | NCT00096733 | Cirrhosis Hepatitis C Hepatocellular ... | 18 Years - | Arbor Research Collaborative for Health | ||
| Multi-center Clinical Application of Hangzhou Criteria in Liver Transplantation for Hepatocellular Carcinoma | NCT03985644 | HCC Liver Transplan... | 18 Years - 75 Years | Zhejiang University | ||
| The Effect of Vitamin D Repletion in Patients With Hepatocellular Carcinoma on the Orthotopic Liver Transplant List | NCT01575717 | Vitamin D Defic... Hepatocellular ... | Vitamin D3 4000... Vitamin D3 2000... | 18 Years - | Icahn School of Medicine at Mount Sinai | |
| Living Donor Liver Transplant for Unresectable Colorectal Liver Metastases | NCT05248581 | Colorectal Canc... | Liver transplan... | 18 Years - | University of Rochester | |
| Liver Transplantation in Patients With Unresectable Colorectal Liver Metastases Treated by Chemotherapy | NCT02597348 | Liver Metastasi... Colorectal Canc... Metastasis | Liver Transplan... | 18 Years - 65 Years | Assistance Publique - Hôpitaux de Paris | |
| Dual Hypothermic Oxygenated Machine Perfusion in Liver Transplantation Using Allografts From Donors After Brain Death | NCT04812054 | Liver Cirrhosis Liver Tumor Liver Transplan... | Hypothermic oxy... Simple cold sto... | 18 Years - | Medical University of Warsaw | |
| Abdominal Regional Perfusion in Donation After Cardiac Death for Multi-Organ Transplantation | NCT03946852 | Liver Transplan... Ischemia Reperf... Cirrhosis Liver Cancer Liver Metastase... End Stage Liver... | Abdominal Regio... | 18 Years - 75 Years | London Health Sciences Centre | |
| Neo-adjuvant Peptide Receptor Mediated Radiotherapy With 177Lutetium in Front of Curative Intended Liver Transplantation in Patients With Hepatic Metastasis of Neuroendocrine Tumors (NEO-LEBE) | NCT01201096 | Liver Metastasis Neuroendocrine ... | 177Lutetium Liver transplan... | 18 Years - 60 Years | University of Jena | |
| Expansion of Conventional Criteria for Liver Transplantation in Hepatocellular Carcinoma Through Downstaging | NCT01387503 | Carcinoma, Hepa... Cirrhosis | Liver transplan... | 18 Years - 65 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Adult-to-Adult Living Donor Transplant Cohort Study | NCT01619475 | Liver Diseases Hepatocellular ... End Stage Liver... Hepatitis C Liver Cirrhosis | 18 Years - | Arbor Research Collaborative for Health | ||
| Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation | NCT00080236 | Liver Transplan... Hepatitis Cholestasis Carcinoma, Hepa... | IDN-6556 Placebo | 18 Years - | Conatus Pharmaceuticals Inc. | |
| Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients | NCT05171335 | Hepatocellular ... | Lenvatinib Transcatheter A... | 18 Years - | The Methodist Hospital Research Institute | |
| AFP Model and Liver Transplantation. | NCT03775863 | Liver Carcinoma Liver Transplan... | Liver transplan... | - | Austral University, Argentina | |
| Liver Transplant for Stable, Advanced Intrahepatic Cholangiocarcinoma | NCT04195503 | Cholangiocarcin... | Liver Transplan... | 18 Years - | University Health Network, Toronto | |
| Liver Transplant for Larger Hepatocellular Carcinoma in Malatya: The Role of GGT and AFP | NCT04412161 | Hepatocellular ... Liver Transplan... | Liver transplan... | - | Inonu University | |
| Impact of Postoperative Adjuvant Chemotherapy in Patients With Hepatocellular Carcinoma After Liver Transplantation | NCT01125020 | Liver Transplan... Hepatocellular ... Tumor Recurrenc... Survival Adjuvant Chemot... | gemcitabine and... doxorubicin, 5-... | 18 Years - | Shanghai Jiao Tong University School of Medicine | |
| Relenvatinib in the Tatment of Recurrence of Hepatocellular Carcinoma After Liver Transplantation | NCT04237740 | Hepatocellular ... Liver Transplan... | relenvatinib | 18 Years - 75 Years | RenJi Hospital | |
| A2ALL-Patients Safety System Improvements in Living Donor Liver Transplantation | NCT02073435 | Liver Diseases Hepatocellular ... Endstage Liver ... Liver Cirrhosis | Donor pain mana... | 21 Years - 60 Years | Northwestern University | |
| Serum Glycomics as Prognostic and Diagnostic Biomarkers of Disease Recurrence in Liver Transplant Recipients With Hepatocellular Carcinoma | NCT05866783 | Prognostic Biom... Liver Transplan... Diagnostic Biom... Hepatocellular ... | HCCRecurrencePr... HCCRecurrenceDi... | 18 Years - | University Hospital, Ghent |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
